Patrick Hope, Executive Director of Medical Imaging & Technology Alliance (MITA)

Move would support patients and encourage innovation.

FDA regulators moved quickly to accelerate the delivery of replacement parts for imaging equipment that has proven to be critical tools in the diagnosis and treatment of COVID-19.